2.7.1.52	1,1,1-trichlorethyl 6-deoxy-alpha-L-galactopyranoside	10 mM, 87% inhibition	51213	
2.7.1.52	2-fluoro-L-fucose	-	213293	
2.7.1.52	4,6-dideoxy-4-azido-alpha-L-glucopyranose	10 mM, 9% inhibition	112611	
2.7.1.52	4,6-dideoxy-4-fluoro-L-gluco-pyranose	10 mM, 30% inhibition	112612	
2.7.1.52	4,6-dideoxy-4-iodo-L-glucopyranose	10 mM, 75% inhibition	51378	
2.7.1.52	4,6-dideoxy-L-xylo-hexopyranose	10 mM, 74% inhibition	51379	
2.7.1.52	ADP	4.9 mM, 96% inhibition, competitive with ATP	13	
2.7.1.52	ADP	-	13	
2.7.1.52	AMP	5.0 mM, 14% inhibition in presence of ATP	30	
2.7.1.52	CDP	4.9 mM, 16% inhibition in presence of ATP	212	
2.7.1.52	Co2+	complete inhibition at 20 mM	23	
2.7.1.52	CTP	4.9 mM, 30% inhibition in presence of ATP	60	
2.7.1.52	D-arabinose	0.5 mM, 20% inhibition. 10 mM, 84% inhibition	565	
2.7.1.52	EDTA	-	21	
2.7.1.52	Fe2+	complete inhibition at 20 mM	25	
2.7.1.52	GDP-L-fucose	competitive with L-fucose	282	
2.7.1.52	GDP-L-fucose	-	282	
2.7.1.52	GDP-L-fucose	less than 30% inhibition at 0.2 mM	282	
2.7.1.52	GTP	0.1 mM, 59% inhibition in presence of ATP	37	
2.7.1.52	GTP	-	37	
2.7.1.52	L-fucose	substrate inhibition at high concentrations	717	
2.7.1.52	L-fucose	0.5 mM	717	
2.7.1.52	L-galactose	weak	1926	
2.7.1.52	methyl 3,6-dideoxy-alpha-L-xylo-hexopyranoside	10 mM, 17% inhibition	113785	
2.7.1.52	methyl 4,6-dideoxy-4-iodo-alpha-L-glucopyranoside	10 mM, 54% inhibition	113786	
2.7.1.52	methyl 4,6-dideoxy-alpha-L-xylo-hexopyranoside	10 mM, 9% inhibition	113787	
2.7.1.52	methyl 6-deoxy-2-O-dodecanoyl-alpha-L-galactopyranoside	10 mM, 37% inhibition	113788	
2.7.1.52	methyl 6-deoxy-alpha-L-galactopyranoside	10 mM, 89% inhibition	51776	
2.7.1.52	octyl 6-deoxy-alpha-L-galactopyranoside	10 mM, 40% inhibition	114177	
2.7.1.52	TTP	4.8 mM, 45% inhibition in presence of ATP	523